Your Location:
Home >
Browse articles >
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Updated:2025-05-07
    • Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway

      Enhanced Publication
    • “The latest research has found that saponins L from Gynostemma pentaphyllum effectively reduce the proliferation and migration ability of ovarian cancer cells by inhibiting their glycolysis pathway, providing new ideas for the treatment of ovarian cancer.”
    • DONG Yuanguang , SONG Nan , YANG Ying , ZHU Jingxuan , WANG Jiaxin , YUAN Mingdian , SUN Yingying
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 11, Pages: 118-124(2025)
    • DOI: 10.13422/j.cnki.syfjx.20250319     

      CLC:
    • Accepted:05 March 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 2 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

467

Views

625

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L Inducing Ovarian Cancer Cell Apoptosis by Regulating NUF2 and Influencing Magnesium Homeostasis
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
Study on Reducing Hepatotoxicity and Retaining Anti-osteoporosis Activity of Psoraleae Fructus Though Salt Processing Based on Zebrafish
Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway

Related Author

DONG Yuanguang
YUAN Mingdian
SUN Yingying
YANG Ying
ZHAO Jiao
SUN Xiaofei
WANG Jiaxin
CUI Peng

Related Institution

Liaoning University of Traditional Chinese Medicine
Liaoning Cancer Hospital
Affiliated Hospital of Liaoning University of TCM
General Hospital of Ningxia Medical University
School of Clinical Chinese Medicine, Gansu University of Chinese Medicine